Express Pharma

facebook
twitter
google_plus
Email

Browsing tag

Syngene

Biocon Q1FY20 Revenue grows by 25 per cent

Syngene announces Q1 FY20 results

Syngene seeks approval for IPO, files DRHP

Home
- Drug approvals
- Deals
- Policies
- Technology
- Leadership
- Research
- AYUSH
- Logistics
- Infrastructure
- Marketing
- HR
- Biotech
Cover Story
Features
Specials
Guest Blogs
Interviews
Editor’s note
Events
Videos
- Get Updated! Series
Downloads
More
- Contact Us

View Desktop Version